CD34 and inflammatory breast carcinoma: This subset of ILC with loss of CD34+ fibroblasts resembles the stromal characteristics of IBC-NST [13], whereas 26% of the studied cases demonstrate a predominantly or uniformly positive tumor stroma for CD34+ fibroblasts, pointing to the existence of distinct stromal subtypes for ILC.